NCT04958720 Spanish Registry of Esophagogastric Cancer
| NCT ID | NCT04958720 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación Sociedad Española de Oncologia Médica |
| Condition | Esophageal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-04-27 |
| Primary Completion | 2034-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-04-27 with a primary completion date of 2034-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to development of a database through a web page for epidemiological and clinical research purposes that is accessible to members of the AGAMENON - SEOM group that guarantees a rigorous collection, exploitation and analysis of the data and information contained, increases the knowledge of esophageal and stomach cancer in order to optimize the management, treatment and evolution of patients, the possibility of comparing variables with those of other series or groups, and promotes the quality of scientific publications.
Eligibility Criteria
Inclusion Criteria: * Adult patient (≥18 years) diagnosed with carcinoma of the esophagus, gastroesophageal junction and stomach, including all histologic subtypes, with or without erbB2 overexpression (and tumors in which this data is unknown). * Follow-up of at least 3 months with clinical information during this period, exempting patients with early death from any cause. Exclusion Criteria: * A patient for whom, for whatever reason, the information necessary to complete the database cannot be known or obtained.
Contact & Investigator
Paula Dr Jiménez Fonseca, MD-PhD
PRINCIPAL INVESTIGATOR
Sociedad Española de Oncología Medica (SEOM)
Frequently Asked Questions
Who can join the NCT04958720 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Esophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04958720 currently recruiting?
Yes, NCT04958720 is actively recruiting participants. Contact the research team at palucaji@hotmail.com for enrollment information.
Where is the NCT04958720 trial being conducted?
This trial is being conducted at Alicante, Spain, Elche, Spain, Elda, Spain, Córdoba, Spain and 11 additional locations.
Who is sponsoring the NCT04958720 clinical trial?
NCT04958720 is sponsored by Fundación Sociedad Española de Oncologia Médica. The principal investigator is Paula Dr Jiménez Fonseca, MD-PhD at Sociedad Española de Oncología Medica (SEOM). The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.